Bendamustine and Melphalan in Myeloma

NCT03187223 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Melphalan
DRUG: Bendamustine

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]